Menu
Search
|

Menu

Close
X

Grifols SA GRFS.OQ (NASDAQ Stock Exchange Global Select Market)

22.86 USD
-- (--)
As of Feb 20
chart
Previous Close 22.86
Open --
Volume --
3m Avg Volume 125,390
Today’s High --
Today’s Low --
52 Week High 25.17
52 Week Low 17.18
Shares Outstanding (mil) --
Market Capitalization (mil) --
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 4 analysts

KEY STATS

Revenue
No Data Available
FY
-
FY
-
FY
-
FY
-
EPS
No Data Available
FY
-
FY
-
FY
-
FY
-

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
35.76
Price to Sales (TTM)
vs sector
--
8.59
Price to Book (MRQ)
vs sector
--
5.23
Price to Cash Flow (TTM)
vs sector
--
26.13
Total Debt to Equity (MRQ)
vs sector
--
15.32
LT Debt to Equity (MRQ)
vs sector
--
11.95
Return on Investment (TTM)
vs sector
--
13.59
Return on Equity (TTM)
vs sector
--
15.20

EXECUTIVE LEADERSHIP

Victor Grifols Roura
Non-Executive Chairman of the Board, Since 2017
Salary: --
Bonus: --
Victor Grifols Deu
Co-Chief Executive Officer, Executive Director, Since 2017
Salary: --
Bonus: --
Raimon Grifols Roura
Co-Chief Executive Officer, Executive Director, Since 2017
Salary: --
Bonus: --
Thomas Daga Glanzmann
Non-Executive Vice Chairman of the Board, Since 2017
Salary: --
Bonus: --
Alfredo Arroyo Guerra
Chief Financial Officer, Since 2014
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

Avinguda de la Generalitat
152, Parque empresarial Can Sant
SANT CUGAT DEL VALLES   BAR   08174

Phone: +34935.712199

Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma for therapeutic use. The Hospital division offers non-biological pharmaceutical products and medical supplies for hospital pharmacy. The Diagnostic division provides clinical analysis and laboratory testing tools to laboratories, hospitals and blood banks. The Raw materials division includes sales of intermediate biological products, as well as manufacturing services to third parties. The Company operates production facilities in Spain, the United States, Mexico and Australia, among others. It controls numerous subsidiaries, such as Kiro Grifols SL.

SPONSORED STORIES